Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-2-18
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0340-6245
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-6
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11858184-Antithrombin III, pubmed-meshheading:11858184-Biological Markers, pubmed-meshheading:11858184-Female, pubmed-meshheading:11858184-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:11858184-Fibrinolysis, pubmed-meshheading:11858184-Hemostasis, pubmed-meshheading:11858184-Humans, pubmed-meshheading:11858184-Labor, Obstetric, pubmed-meshheading:11858184-Peptide Hydrolases, pubmed-meshheading:11858184-Plasminogen Activator Inhibitor 1, pubmed-meshheading:11858184-Plasminogen Activator Inhibitor 2, pubmed-meshheading:11858184-Postpartum Period, pubmed-meshheading:11858184-Pregnancy, pubmed-meshheading:11858184-Pregnancy Trimester, Second, pubmed-meshheading:11858184-Pregnancy Trimester, Third, pubmed-meshheading:11858184-Reference Values, pubmed-meshheading:11858184-Tissue Plasminogen Activator, pubmed-meshheading:11858184-Urokinase-Type Plasminogen Activator
pubmed:year
2002
pubmed:articleTitle
Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
pubmed:publicationType
Letter